Logo image
New search Researchers Research units
Sign in
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder : a double-blind, placebo-controlled comparison with intramuscular haloperidol
Journal article   Peer reviewed

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder : a double-blind, placebo-controlled comparison with intramuscular haloperidol

Raisa Andrezina, Richard C Josiassen, Ronald N Marcus, Dan A Oren, George Manos, Elyse Stock, William H Carson and Taro Iwamoto
Psychopharmacologia, v 188(3), pp 281-292
Oct 2006
PMID: 16953381

Abstract

Adult and adolescent clinical studies Biological and medical sciences Medical sciences Neuropharmacology Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Psychoses Schizophrenia

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Web of Science research areas
Neurosciences
Pharmacology & Pharmacy
Psychiatry
Logo image